Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.5B | 7.4B | 6.9B | 5.4B |
| Cost of revenue | 1.6B | 1.6B | 1.3B | 1.3B |
| Gross profit | 4.9B | 5.8B | 5.6B | 4.1B |
| Operating expense | ||||
| Research & development | 834M | 981M | 845M | 898M |
| Selling general and admin | 1.8B | 2.3B | 1.8B | 2.6B |
| Other operating expenses | 6M | 4M | -15M | -3M |
| Operating income | 1.4B | 1.7B | 2.0B | 612M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.1B | 1.4B | 1.7B | 275M |
| Tax provision | 221M | 47M | 248M | 51M |
| Net income | 875M | 1.4B | 1.5B | 224M |
| Basic EPS | 2.6 | 4.1 | 4.3 | 0.7 |
| Diluted EPS | 2.5 | 4.0 | 4.2 | 0.7 |
| Basic average shares | 343.5M | 343.2M | 343.0M | 340.6M |
| Diluted average shares | 347.0M | 347.1M | 346.8M | 344.7M |
| EBITDA | 2.3B | 2.6B | 3.0B | 1.5B |
| Net income from continuing op. | 1.1B | 1.4B | 1.7B | 275M |
| Minority interests | 0 | 6M | 0 | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |